Glyzia Met 50mg/500mg 14 Tablets

Glyzia Met 50mg/500mg Tablets contain a combination of Sitagliptin and Metformin, used to manage type 2 diabetes by improving blood sugar control. Sitagliptin increases insulin release and reduces glucose production, while Metformin lowers sugar absorption and enhances insulin sensitivity.

Key Benefits:
Supports blood sugar control – Helps regulate glucose levels effectively.
Enhances insulin sensitivity – Improves the body's response to insulin.
Reduces sugar production – Lowers glucose release from the liver.
Combination therapy – Provides dual action for better diabetes management.

Who It’s For:
✓ Individuals with type 2 diabetes who require combination therapy.
✓ Not suitable for those with type 1 diabetes, severe kidney disease, or metabolic acidosis.

Side Effects:
✓ Common: Nausea, diarrhea, stomach discomfort, mild headache.
✓ Serious (rare): Lactic acidosis, pancreatitis, severe allergic reactions.

Warnings & Precautions:
Monitor blood sugar levels regularly to avoid hypoglycemia.
Do not consume excessive alcohol as it may increase the risk of lactic acidosis.
Consult a doctor if you have kidney, liver, or heart conditions.

Dosage:
As prescribed by a doctor. Typically one tablet twice daily with meals.

Additional Information:
1. Prescription Required: Yes.
2. Generic Name(s): Sitagliptin + Metformin.
3. Pregnancy Category: Consult your doctor before use during pregnancy or breastfeeding.
4. When Not to Use: Avoid if you have severe kidney disease, type 1 diabetes, or metabolic acidosis.

Storage:
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.